Monday, October 21, 2019

Lab Grown Fish: "Wild Type Announced a $12.5M Series A for Cell Cultured Salmon"

From Global AgInvesting:
Cultured seafood production got another vote of investor confidence as Wild Type announced it has closed a $12.5 million Series A led by CRV, and including Maven Ventures, and return investors from the startup’s Seed round, Spark Capital and Root Ventures. This round marks the first Series A secured by a cell-cultured seafood startup.

Founded in San Francisco by former U.S. diplomat Justin Kolbeck and aspiring cardiologist Arye Elfenbe in 2016, Wild Type’s initial goal was to  “address the most pressing challenges of our generation: climate change, food security, and health.” To achieve this, the company’s team of food scientists, engineers, biologists, and biomedical engineers have developed cell-cultured salmon that can meet global demand while also increasing transparency and traceability in a global industry that has had a long history of discrepancies in its often opaque supply chain.

This round brings the company’s funding to $16 million following a $3.5 million Seed round in April 2018 led by Spark Capital, and including Root Ventures, Mission Bay Capital, and a group of angel investors....MORE
The writer goes on to name some other lab-grown food companies but does not answer the question:
What is an aspiring cardiologist?